These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1689237)

  • 1. Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats.
    Otsuki M; Tani S; Okabayashi Y; Fuji M; Nakamura T; Fujisawa T; Itoh H
    Dig Dis Sci; 1990 Feb; 35(2):242-50. PubMed ID: 1689237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
    Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y
    Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective effect of the trypsin inhibitor urinastatin on cerulein-induced acute pancreatitis in rats.
    Tani S; Otsuki M; Itoh H; Nakamura T; Fujii M; Okabayashi Y; Fujisawa T; Baba S
    Pancreas; 1988; 3(4):471-6. PubMed ID: 2459695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats.
    Leonhardt U; Seidensticker F; Stöckmann F; Creutzfeldt W
    Pancreas; 1993 Jan; 8(1):98-102. PubMed ID: 7678329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting prevents acute pancreatitis induced by cerulein in rats.
    Otsuki M; Tani S; Okabayashi Y; Fujii M; Nakamura T; Fujisawa T; Koide M; Itoh H
    Dig Dis Sci; 1990 Jul; 35(7):840-8. PubMed ID: 2364838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a low-molecular weight serine proteinase inhibitor (camostate) on amylase release from isolated pancreatic acini.
    Göke B; Leferink J; Göke R; Adler G
    Res Exp Med (Berl); 1989; 189(1):33-8. PubMed ID: 2469115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.
    Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W
    Digestion; 1984; 30(3):171-8. PubMed ID: 6209186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerulein-induced acute pancreatitis in the rat. Study of pancreatic secretion and plasma VIP and secretin levels.
    Manso MA; San Román JI; de Dios I; García LJ; López MA
    Dig Dis Sci; 1992 Mar; 37(3):364-8. PubMed ID: 1370934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of preventive oral administration of camostate on cerulein-induced pancreatitis in rats.
    Kisfalvi K; Papp M; Friess H; Büchler M; Gorácz UG
    Dig Dis Sci; 1995 Mar; 40(3):546-7. PubMed ID: 7741926
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
    Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB
    Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
    Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
    Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
    Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
    Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic fluid hypersecretion in rats after acute pancreatitis.
    Czakó L; Yamamoto M; Otsuki M
    Dig Dis Sci; 1997 Feb; 42(2):265-72. PubMed ID: 9052504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats.
    Miyasaka K; Nakamura R; Kitani K
    J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
    Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
    Cancer Lett; 1991 Dec; 60(3):205-11. PubMed ID: 1756510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptation of the human pancreas to inhibition of luminal proteolytic activity.
    Friess H; Kleeff J; Isenmann R; Malfertheiner P; Büchler MW
    Gastroenterology; 1998 Aug; 115(2):388-96. PubMed ID: 9679044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soybean trypsin inhibitor and cerulein accelerate recovery of cerulein-induced pancreatitis in rats.
    Jurkowska G; Grondin G; Massé S; Morisset J
    Gastroenterology; 1992 Feb; 102(2):550-62. PubMed ID: 1370663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effects of long-acting recombinant human pancreatic secretory trypsin inhibitor (R44S-PSTI) in a rat model of cerulein-induced pancreatitis.
    Chen YZ; Ikei S; Yamaguchi Y; Sameshima H; Sugita H; Moriyasu M; Ogawa M
    J Int Med Res; 1996; 24(1):59-68. PubMed ID: 8674801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of trypsin inhibitor on the pancreas and small intestine of mice.
    Ge YC; Morgan RG
    Br J Nutr; 1993 Jul; 70(1):333-45. PubMed ID: 8399113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.